CRISPR Therapeutics AG’s filing revealed that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.17 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.17 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. CRISPR Therapeutics
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.45 million